chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm stiffness; soreness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (arm stiffness) and MYALGIA (soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002AZIA and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (arm stiffness) and MYALGIA (soreness). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (arm stiffness) and MYALGIA (soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.
11/11/2022 I had been exposed to COVID. I started with a tickle in my throat on November 11, 2022. I tested negative for COVID on 11/11/22 and 11/12/22. I tested on 11/13/22 and tested positive. On 11/13/22 I did a telehealth with a doctor. I then texted with my PCP to ask what she felt about me taking PAXLOVID. She ordered it and I started taking it that evening. I had no symptoms. On day 10 after the positive test, I tested for COVID, and I was negative. I was negative for three days. Then I tested again on Day 14 and, I was positive. It was 10 days after that before I tested negative again. I did have a slight runny nose for one day. I have totally recovered.
flushing, felt dizzy. given Benadryl 50mg and resolved in 15 minutes
Information has been received from a registered nurse concerning a 15 year old female patient with no known drug allergies with a history of spontaneous abortion (in February 2010) who on 07-SEP-2010, was vaccinated IM with the first 0.5 ml dose of GARDASIL (Lot# 666595/0703Z). On 15-SEP-2010, the patient was vaccinated IM with the second 0.5 ml dose of GARDASIL (lot# 666163/0664Z) and on 02-NOV-2010, the patient was vaccinated IM with the third 0.5 ml dose of GARDASIL (lot# 666595/0703Z). There were no concomitant therapies. It was reported that on 07-SEP-2010, the patient was given the first dose of GARDASIL by error. The nurse stated that "should have been vaccines for children which they did not have in their clinic". On 15-SEP-2010, the patient repeated the "first dose" of GARDASIL at her high school in error since the patient did not report she had already received the vaccine and the staff did not know she received it. The nurse stated that on 02-NOV-2010, the patient received by error the "second dose" of GARDASIL by then due to they should have been vaccinated the patient with vaccines for children program. There was no adverse effect reported. This is one of several reports from the same source. No further information is available.
I tested positive for COVID-19 on 12/27/2022. I had a bad cough and that was pretty much it. I started taking over-the-counter medication, Mucinex and Nyquil. I contacted the doctor, and she did not think it was necessary to prescribe medications. I finally have a productive cough. I have taken Excedrin the past 2 days because I have had a headache, but other than that I feel fine.
Felt fine for first two weeks (other than a few hours of nausea 36 hours post vaccination).  Now, 2 weeks later, may inoculation site  became minimally itchy and  two days later I noticed a rash around the site, which has been growing larger.  It is not hot or swollen, but is tender/sore.
Rash over face and arms intiailly reported-progressed to include Koplik spots, light sensitivity, no fever 2/4/14-headache, loss of appetite.
This spontaneous report was received from a healthcare worker referring to a patient of unknown age and gender. Healthcare worker reported that on 18-SEP-2014, the patient was vaccinated with an expire dose of M-M-R II (lot # reported as H017046, expiration date 17-SEP-2014). No adverse effects reported. Additional information is not expected.
Information has been received from a physician concerning a 16 week female who on 16-NOV-2007 was vaccinated with the second of ROTATEQ. Concomitant therapy included DTap-Hib (OMPC) (manufacturer unknown), poliovirus vaccine and pneumococcal vaccine (unspecified). On 19-NOV-2007 or 20-NOV-2007, the patient experienced vomiting episode and right after vomiting shortness of breath. The patient was sent to the emergency room and was informed that she had a stomach virus. Patient was stop breast feeding afterwards. Subsequently, the patient recovered. Additional information has been requested.
Low fever, aches, chills, pain and swelling in arm.  Tiinnitis was noticed about 6 months after booster.
Migraine/headache in AM and PM for 6 days straight post vaccine, treated with Advil as needed. Cough that has continued from date of vaccine administration until today (still active) and I was not coughing prior to vaccine. Very painful arm at location of vaccine for 4 days post injection.
Large swelling at injection site. Site warm to the touch. Patient complained of fever and feeling tired.
Upon assessment the deltoid region (approx size of an orange in diameter) is with edema, erythema, and is feverish to touch.  There is a small dime size bruise in the center of the erythema and Veteran reports slight left upper extremity discomfort with ROM. Cool compress applied, PRN medication management as ordered
I received the second dose of the vaccine on October 27, 2021.   By 6 PM I wasn?t able to get out of bed with the following symptoms, 103° Fever, severe malaise, severe myalgia, severe joint pain, dizziness, headache, mild chest pain, abdominal discomfort, neurological (visual, muscular, and neuropathy in fingers and toes .  Many of these symptoms have persisted until this day.  On day 4 I developed an SVT and needed intervention including cardioversion.  Chest pain increased over the next 3 weeks and I went to the emergency department on 11/23/21 and was diagnosed with lung pleurisy and a heart murmur.  All symptoms are persistent to this day with waxing and waning severity.
this was administered into fat (ie. not IM); First injection site was erythematous, not swollen or painful, covering ~10cm x 10cm; First injection site was erythematous/began to itch after 8-10 days; large diffuse, blotchy bruise surrounded by erythema; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 48-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration in right leg on 03Feb2021 09:30 (at the age of 48-year-old) as 1st dose, single for COVID-19 immunisation. Medical history included hx of (TIA) transient ischaemic attack from an unknown date and unknown if ongoing, found to be heterozygous for factor V Leiden and diagnosed PFO (repaired) from an unknown date and unknown if ongoing, PFO from an unknown date and unknown if ongoing diagnosed PFO (repaired). Known allergies were azithromycin and penicillin. Concomitant medications included minerals nos, vitamins nos (ONE A DAY [MINERALS NOS;VITAMINS NOS]) taken for an unspecified indication, start and stop date were not reported; aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) 81 mg taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. No treatment received for adverse event, no covid prior vaccination and did not tested covid post vaccination. On Feb2021, it was reported that first injection site was erythematous, not swollen or painful, covering ~10cm x 10cm; began to itch after 8-10 days; now appears as a large diffuse, blotchy bruise surrounded by erythema. I am as sure as I can be that this was administered into fat (i.e. not IM) on 03Feb2021 09:30. The clinical outcome for the events was unknown.   Follow-up attempts completed. No further information expected.
full body aches, throbbing joints, centralized headache for 48 hours.  responsive to Advil.
PATIENT HAD RECEIVED PARTIAL DOSE OF JANSSEN AS AN 1-2ML DRIPPED OUT OF SYRINGE; SYRINGES RECEIVED WITH THE VACCINE WERE DULL, SOME CONTENTS SPILLED OUT OF SYRINGE / NEEDLE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included coronary disease, gastroenterologist consultation (gi consult), polymyalgia/rheumatica, foraminal stenosis cervical region, and hypertension (htn), and other pre-existing medical conditions included no information on allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced subject had received partial dose of janssen as an 1-2ml dripped out of syringe. On 09-MAR-2021, the subject experienced syringes received with the vaccine were dull, some contents spilled out of syringe / needle. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the patient had received partial dose of janssen as an 1-2ml dripped out of syringe and syringes received with the vaccine were dull, some contents spilled out of syringe / needle was not reported. This report was non-serious. The suspected product quality complaint has been confirmed to be voided: did not meet pqc criteria based on the PQC evaluation/investigation performed.
Dose administered to patient after more than 1 temperature excursion; Dose administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered to patient after more than 1 temperature excursion) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 1:32 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 1:32 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Dose administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered to patient after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 69.30 for dose administered on 15-APR-2021.  No concomitant medications were reported.  Batch number 044B21A underwent temperature excursion on 15-Apr-2021 with temperature 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 06-Apr-2021 and beyond use date for the vial was reported as 09-May-2021. Product moved to clinic on 15-Apr-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
Medical history of "controlled" and "stable" proteinuria from 2005 to 2020. Before any mRNA vaccine Micoralbumin/Creatinine  on 10/10/20 was "stable" at 392.4mcg/mg. In both primary Moderna vaccines (noted after second dose), proteinuria worsened, which was also reported. Moderna Booster received 11/18/21 proteinuria never got back to pre-vaccine levels and then also worsened after booster: Micoralbumin/Creatinine in urine on 8/10/21 was 685 (and NEVER returned to pre-mRNA vaccine level), per nephrologist request suggestion received Booster on 11/18/21, Microalb/Creatinine on 12/10/11 increased to 1,162, & on 4/22/22 not only remained elevated but again increased to 1,322. As a result Nephrologist recommending renal biopsy (last in 2010, w/ history of glomerulonephritis) and start Chemotherapy and Prednisone treatment.
pt recvd vax 24AUG93; w/in 1 hr pt devel generalized urticaria; tx w/DPH; resolved approx 1 hr later; this was pt's first DTP (DTAP) immun for pt because parents refused earlier doses;
My teeth and gums started hurting the week after the first shot. They hurt 24/7. It is worse in the front but is throughout the mouth. There is no bleeding and I don't have a history of gum disease. I brush and floss regularly and see my dentist twice a year. There is sensitivity to hot and cold foods but also it hurts to eat anything but very soft foods. It hurts to chew food. I don't know for sure whether the vaccine is the cause. I am submitting this report because of the timing of onset and because I don't know for sure. I had the first Moderna shot at 2:40 PM on April 5, 2021. I had the second shot at 2:40 on May 3, 2021. Other post-vaccine symptoms that were temporary include extreme fatigue that lasted about a week, brain fog for a couple days, arm soreness, and tachycardia the day after.
Pt recvd vax & w/in 1 wk of 3rd dose exp abdo pain & edema in liver; resolved in 10 days;
I started having bad headaches the day after the vaccine. A few days later I saw blood in my stool. I have experienced blood in my stool seven times up to this point. I have been feeling slight numbness in my biceps and calves. I have also been very sleepy and fatigued. Another thing is also pain around my rib cage area. I have also experienced some shortness of breath.
Slight headache; Itches; Rash under where she got the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itches), VACCINATION SITE RASH (Rash under where she got the injection) and HEADACHE (Slight headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itches) and VACCINATION SITE RASH (Rash under where she got the injection). On 10-Feb-2021, the patient experienced HEADACHE (Slight headache). At the time of the report, VACCINATION SITE PRURITUS (Itches), VACCINATION SITE RASH (Rash under where she got the injection) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included: unspecified medication for diabetes, unspecified medication for cholesterol. No treatment medication was provided.
Tinnitus from Shingrix vaccine; This case was reported by a other health professional via interactive digital media and described the occurrence of tinnitus in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced tinnitus. On an unknown date, the outcome of the tinnitus was unknown.   The reporter considered the tinnitus to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was selected as per the vaccine indication. The age at vaccination was not reported. After receiving the Shingrix the patient experienced tinnitus.
Within 2 minutes after giving the vaccine, the patient complained of headache and stomach ache. The patient then fainted and knocked over a display as he fell. 911 was called and EPI-PEN was prepared. EPI-PEN was not used since patient regained consciousness within a few seconds. He slowly regained his senses and within 2 minutes was only complained of a hurt shoulder from the impact. Emergency workers came to monitor and test patient but found no maladies. They did not recommend further treatment. Patient left within 30 minutes without complaints other than hurt shoulder.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced MYALGIA (Sore arm). On 08-Apr-2021, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The concomitant medications were not reported  The treatment information was not provided.   Reporter did not allow further contact
Pt received flu shot yesterday 10-9-09, per mother pt woke up today at 7:00 AM with the skin where shot was given red and warmth to touch, size of 7 cm w by 5 1/2 cm. No fever or other sx noted.
chills, fever, body ache, headache, weakness   redness and swelling of right arm
A few days after receiving my vaccine, I woke up and noticed that I felt some discomfort in my left arm. It felt like a nervy sensation in the vicinity of where the vaccine was given. It's hard to describe but it felt internal. I'm not sure if it was muscular or nerve. Initially it was pretty intense, but it got better as time progressed. Even today, if I move my arm a certain way, I still feel some discomfort.
HEADACHE; MUSCLE PAIN; TIREDNESS; This spontaneous report received from a patient concerned an 18 year old female. The patient's weight was 65 kilograms, and height was 71 inches. The patient's concurrent conditions included von willebrand disease, abstains from alcohol, non-smoker, and allergic to nsaids, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 03:11 to Right Deltoid for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced headache. On 08-MAR-2021, the subject experienced muscle pain. On 08-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, muscle pain, and tiredness. This report was non-serious.
Customer got light headed , then vomited x 2 .  Got real sleepy and cold and clammy for about  10-15 minutes.  Call EMS and customer was fine by the time they arrived. She had color back to her skin and laughing.  She went home with her mother
Patient received shot and sat for 15 minutes, left and came back and reported she felt woozy. She felt dizzy. Patient stated she felt dizzy off and on while she was in clinic getting shot, patient left.
I felt under the weather, the evening after the vaccination. I was back to normal after 24 hours.  I didn't take anything and it was gone by the next day.
Fever 101.9 degrees, sore throat and headache 0300 10/4/02.
woke up in the middle of the night with fever, chills, nausea, body aches, diarrhea
9/29/2021-left underarm pain (underarm hurt when moving arm),  lymph node palpable.  Symptoms resolved on 6/2/2021.  No treatment required.   6/1/2021- left deltoid rash (red rash, warm to touch, itching).  Symptoms resolved on 6/4/2021.  No treatment required.
Strange feeling in chest when leaning over, then a few days later gradually over 2 weeks more intense pain in chest on left side enough to wake at night several times with rapid heart beat
Achy all over Headache Nausea Injection Site red/swollen No Energy-Very Exhausted-Tired It took about 3-4 days after injection to start feeling normal again
shingles diagnosis following Shingrix series; shingles diagnosis; Pain on right ear / right ear pain as sharp stabs of pain radiating inward on external ear; Rash rash as located underneath earlobe and radiating along right jaw line; This case was reported by a nurse via call center representative and described the occurrence of suspected vaccination failure in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On 23rd March 2020, unknown after receiving Shingrix and Shingrix, the patient experienced ear pain and rash. On 24th March 2020, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with decadron (nos) (Decadron). On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the ear pain and rash were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, ear pain and rash to be related to Shingrix and Shingrix.  Additional details were provide as follows: The age at vaccination was not reported. The patient received a Shingrix series. No lot number or expiration date provided. No date of administration of dose one or two of series provided. On n Monday morning but exact time provided, the patient experienced right ear pain as sharp stabs of pain radiating inward on external ear. On n Monday night just before bed, but exact time provided, the patient experienced rash as located underneath earlobe and radiating along right jaw line.  The patient received a Decadron injection and a prescription for Valtrex and was diagnosed with shingles. On 25th March 2020, the symptoms were begun to abate. no additional details were given. This case was considered as suspected vaccination failure as details regarding time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
PATIENT CAME IN ON 10/05/2023, FEVER AND RASH OVER THE BODY ITCHING
Patient received the influenza vaccination on Friday 10/6/2017 to her left arm. She reported vomiting, aches, nausea, runny nose, and headache that began Saturday 10/7. States she had local swelling of arm with numbness and tingling. States she took off work for 2 days (Monday and Tuesday) then returned Wednesday. Contacted employee health clinic Thursday (10/12) for evaluation.